Lichen planus-like drug eruptions due to β-blockers: a case report and literature review.
Abstract
Lichen planus-like drug eruptions (LDE) can appear similar or identical to idiopathic lichen planus. We present a 45-year-old man with a widespread, violaceous, papular, generalized exanthema with histologic features of a lichenoid reaction, which subsequently resolved with the cessation of labetatol. We found 29 cases of previously reported β-adrenoceptor antagonist (β-blocker)-associated LDE. This is a relatively rare complication that may present as classic lichenoid papules indistinguishable from lichen planus and has a predilection for the limbs, chest, back, and oral mucosa. Histologically, there is a lichenoid infiltrate often with eosinophils. LDE may be due to drug cross-reactivity or as a result of a suppressed skin adrenergic system. Multiple potential medications in case studies and the inability to differentiate LDE from idiopathic lichen planus in cross-sectional association studies make any conclusive analysis difficult.
Links
Authors
Fessa C, Lim P, Kossard S, Richards S, Peñas PF
Institution
Department of Dermatology, Westmead Hospital, Westmead, NSW, Australia. cfessa@yahoo.com.au
Source
American journal of clinical dermatology 13:6 2012 Dec 1 pg 417-21MeSH
Adrenergic beta-AntagonistsDrug Eruptions
Humans
Labetalol
Lichen Planus
Male
Middle Aged
Pub Type(s)
Case ReportsJournal Article
Review
Language
eng
PubMed ID
22809321
Log In

